Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate

about

Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate

Item

http://www.wikidata.org/entity/Q36303226

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Patients with pathological sta ...... a lower treatment failure rate

@ast

Patients with pathological sta ...... a lower treatment failure rate

@en

type

Item

label

Patients with pathological sta ...... a lower treatment failure rate

@ast

Patients with pathological sta ...... a lower treatment failure rate

@en

prefLabel

Patients with pathological sta ...... a lower treatment failure rate

@ast

Patients with pathological sta ...... a lower treatment failure rate

@en

P1476

Patients with pathological sta ...... a lower treatment failure rate

@en

P2093

Hua Ren

http://www.w3.org/2001/XMLSchema#string

Hui Fang

http://www.w3.org/2001/XMLSchema#string

Jing Jin

http://www.w3.org/2001/XMLSchema#string

Ning Li

http://www.w3.org/2001/XMLSchema#string

Shu-Lian Wang

http://www.w3.org/2001/XMLSchema#string

Wei-Hu Wang

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Xin-Fan Liu

http://www.w3.org/2001/XMLSchema#string

Yan-Ru Feng

http://www.w3.org/2001/XMLSchema#string

Ye-Xiong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.

Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.

P2888

s12885-017-3170-3

P304

182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3170-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084250519

http://www.w3.org/2001/XMLSchema#string

P698

28279170

http://www.w3.org/2001/XMLSchema#string

P932

5343389

http://www.w3.org/2001/XMLSchema#string